| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |